Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Operating Expenses | 22,241 | 18,286 | 15,699 | 16,155 | 9,024 |
| Operating Income | -22,241 | -18,286 | -15,699 | -16,155 | -9,024 |
| Other Income | 155 | 147 | 176 | 147 | 33 |
| Pre-tax Income | -22,086 | -18,139 | -15,523 | -16,008 | -8,991 |
| Net Income Continuous | -22,086 | -18,139 | -15,523 | -16,008 | -8,991 |
| Net Income | $-22,086 | $-18,139 | $-15,523 | $-16,008 | $-8,991 |
| EPS Basic Total Ops | -0.53 | -0.43 | -0.37 | 0.89 | -0.36 |
| EPS Basic Continuous Ops | -0.53 | -0.43 | -0.37 | 0.88 | -0.36 |
| EPS Diluted Total Ops | -0.53 | -0.43 | -0.37 | 0.89 | -0.36 |
| EPS Diluted Continuous Ops | -0.53 | -0.43 | -0.37 | 0.88 | -0.36 |
| EBITDA(a) | $-21,883 | $-17,919 | $-15,283 | $-15,833 | $-8,937 |